Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could have a ...

Upscale cliffside development The Palisades is on the hook for $1.7 million in fines from the Guam Environmental Protection Agency over a number of violations related to an Oct. 15 landslide that ...